Okami Medical Receives Expanded Indication for the LOBO Vascular Occluder

ALISO VIEJO, Calif., Oct. 7, 2026 /PRNewswire/ -- Okami Medical, a medical technology company developing novel vascular embolization solutions, announced today that the U.S. FDA has granted an expanded indication for its LOBO® Vascular Occlusion System. The expanded indication extends the...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.